Literature DB >> 24780821

Inhibition of transforming growth factor-β signaling potentiates tumor cell invasion into collagen matrix induced by fibroblast-derived hepatocyte growth factor.

Jun Oyanagi1, Nako Kojima1, Haruki Sato1, Shouichi Higashi1, Keiji Kikuchi2, Katsuya Sakai3, Kunio Matsumoto3, Kaoru Miyazaki4.   

Abstract

Interaction between tumor cells and stromal fibroblasts plays essential roles in tumor progression. However, its detailed molecular mechanism remains unclear. To understand the mechanism, we investigated molecules mediating this interaction using the three-dimensional (3D) co-culture system of Panc-1 pancreatic carcinoma cells with normal fibroblasts. When the two kinds of cells were placed on the top of collagen gel, the tumor cells scattered into the fibroblast layer, apparently undergoing epithelial-mesenchymal transition. When fibroblasts were placed within collagen gel, Panc-1 cells actively invaded into the collagen gel, extending a microtubule-based long protrusion. Although transforming growth factor-β (TGF-β) and hepatocyte growth factor (HGF) individually stimulated the tumor cell invasion into collagen gel without fibroblasts, TGF-β signaling inhibitors (SB431542 and LY2157299) significantly enhanced the Panc-1 cell invasion in the 3D co-culture with fibroblasts. Experiments with HGF/Met signaling inhibitors or with the fibroblast conditioned medium revealed that HGF was a major invasion-promoting factor secreted from fibroblasts and SB431542 increased the HGF secretion by blocking the HGF-suppressing activity of cancer cell-derived TGF-β. These results indicate that HGF and TGF-β are critical regulators for both tumor-stroma interaction and tumor invasion. The results also suggest that TGF-β signaling inhibitors may promote tumor progression under some pathological conditions.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer-associated fibroblast (CAF); Collagen; HGF; TGF-β; Tumor invasion; Tumor stroma

Mesh:

Substances:

Year:  2014        PMID: 24780821     DOI: 10.1016/j.yexcr.2014.04.009

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  17 in total

Review 1.  Cancer-associated fibroblasts modulate growth factor signaling and extracellular matrix remodeling to regulate tumor metastasis.

Authors:  Begum Erdogan; Donna J Webb
Journal:  Biochem Soc Trans       Date:  2017-02-08       Impact factor: 5.407

2.  Fibroblast-Conditioned Media Enhance the Yield of Microglia Isolated from Mixed Glial Cultures.

Authors:  Jian Hu; Peng Wang; Zhengyi Wang; Yuyun Xu; Wenshuo Peng; Xiongjian Chen; Yani Fang; Liyun Zhu; Dongxue Wang; Xue Wang; Li Lin; Lixin Ruan
Journal:  Cell Mol Neurobiol       Date:  2022-02-12       Impact factor: 5.046

3.  Priming hMSCs with a putative anti-cancer compound, myrtucommulone-a: a way to harness hMSC cytokine expression via modulating PI3K/Akt pathway?

Authors:  Banu Iskender; Kenan Izgi; Cagri Sakalar; Halit Canatan
Journal:  Tumour Biol       Date:  2015-09-03

Review 4.  TGFB1/INHBA Homodimer/Nodal-SMAD2/3 Signaling Network: A Pivotal Molecular Target in PDAC Treatment.

Authors:  Mai Abdel Mouti; Siim Pauklin
Journal:  Mol Ther       Date:  2021-01-09       Impact factor: 11.454

5.  Adenosine/TGFβ axis in regulation of mammary fibroblast functions.

Authors:  Georgii Vasiukov; Anna Menshikh; Philip Owens; Tatiana Novitskaya; Paula Hurley; Timothy Blackwell; Igor Feoktistov; Sergey V Novitskiy
Journal:  PLoS One       Date:  2021-06-08       Impact factor: 3.240

Review 6.  Hepatocyte Growth Factor from a Clinical Perspective: A Pancreatic Cancer Challenge.

Authors:  Wasia Rizwani; Amanda E Allen; Jose G Trevino
Journal:  Cancers (Basel)       Date:  2015-09-03       Impact factor: 6.639

7.  A polyethylenimine-modified carboxyl-poly(styrene/acrylamide) copolymer nanosphere for co-delivering of CpG and TGF-β receptor I inhibitor with remarkable additive tumor regression effect against liver cancer in mice.

Authors:  Shuyan Liang; Jun Hu; Yuanyuan Xie; Qing Zhou; Yanhong Zhu; Xiangliang Yang
Journal:  Int J Nanomedicine       Date:  2016-12-13

8.  The TGFβ-SMAD3 pathway inhibits IL-1α induced interactions between human pancreatic stellate cells and pancreatic carcinoma cells and restricts cancer cell migration.

Authors:  Vegard Tjomsland; Dagny Sandnes; Ewa Pomianowska; Smiljana Torbica Cizmovic; Monica Aasrum; Ingvild Johnsen Brusevold; Thoralf Christoffersen; Ivar P Gladhaug
Journal:  J Exp Clin Cancer Res       Date:  2016-07-29

Review 9.  Functions of pancreatic stellate cell-derived soluble factors in the microenvironment of pancreatic ductal carcinoma.

Authors:  Qi Wu; Ying Tian; Jingqiu Zhang; Hongpeng Zhang; Fengming Gu; Yongdie Lu; Shengnan Zou; Yuji Chen; Pengxiang Sun; Mengyue Xu; Xiaoming Sun; Chao Xia; Hao Chi; A Ying Zhu; Dong Tang; Daorong Wang
Journal:  Oncotarget       Date:  2017-10-19

Review 10.  Biomarkers and Targeted Therapy in Pancreatic Cancer.

Authors:  Fataneh Karandish; Sanku Mallik
Journal:  Biomark Cancer       Date:  2016-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.